Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early compared to other cancers and can quickly develop resistance to chemotherapy — ...

Scientists at the University of Minnesota's Hormel Institute in Austin recently published a study that looked at a drug that ...

Dopamine doesn’t flood the brain as once believed – it fires in exact, ultra-fast bursts that target specific neurons. The ...

A finding by a McGill-led team of neuroscientists could open doors to new treatments for a range of psychiatric and ...

Dopamine agonists, although considered the first-line agents in management of moderate-to-severe RLS, are not without adverse effects, the most common being nausea, dizziness, ...

Intermittent fasting may help alleviate depression symptoms by targeting dopamine receptors in the brain, according to a new study published in Neurobiology of Disease. Depression is one of the most ...

In the study, tavapadon — which works by mimicking dopamine and targeting the D1/D5 receptors — was found to have the same benefits as levodopa without the adverse effects, according to Hubert ...

Access free, up-to-date clinical references on dopamine receptor agonists at Healio. We aid in making confident point-of-care decisions for type 2 diabetes.

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today ...